Clinical Trial Detail

NCT ID NCT00925132
Title Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Iowa
Indications

melanoma

Therapies

Decitabine + Panobinostat + Temozolomide

Age Groups: adult

No variant requirements are available.